The putative mechanism of thrombosis in antiphospholipid syndrome: Impairment of the protein C and the fibrinolytic systems by monoclonal anticardiolipin antibodies

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue 5, 1999, Pages 503-507

  Ieko, Masahiro ^a   Sawada, Ken Ichi ^b   Koike, Takao ^b   Notoya, Atsushi ^c   Mukai, Masaya ^c   Kohno, Michihumi ^c   Wada, Norio ^c   Itoh, Tomohiro ^c   Yoshioka, Narihito ^c  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c SAPPORO CITY GENERAL HOSPITAL   (Japan)

Author keywords

Activated protein C; Antiphospholipid syndrome; Fibrinolysis; Monoclonal anticardiolipin antibody; 2 glycoprotein I

Indexed keywords

ACTIVATED PROTEIN C; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FIBRINOLYSIS; HUMAN; HUMAN CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; THROMBOGENESIS; THROMBOSIS;

EID: 0033404817     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994958     Document Type: Article

References (20)

1. Hughes GRV, Harris EN, Gharabi AE. The anticardiolipin syndrome. J Rheumatol 1986;13:486-489
2. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990;87: 4120-4124
3. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-1547
4. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990;336:177-178
5. Nimpf J, Bevers EM, Bomans PHH, et al. Interaction of β2 glycoprotein-I with human blood platelets: Influence upon ADP induced aggregation. Thromb Haemost 1985;54:397-401
6. Schouboe I. β2 glycoprotein I: A plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 1985;66:1086-1091
7. Nimpf J, Bevers EM, Bomans PHH, et al. Prothrombinase activity of human platelets is inhibited by β2 glycoprotein-I. Biochim Biophys Acta 1986;884:142-149
8. Ichikawa K, Khamashta MA, Koike T, Matsuura E, Hughes GRV. β2-glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum 1994;37:1453-1461
9. Ieko M, Ichikawa K, Triplett DA, et al. β2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies. Arthritis Rheum 1999;42:167-174
10. Cariou R, Tobelem G, Bellucci, et al. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cell-inhibition of thrombomodulin dependent protein C activation. Thromb Haemost 1988;60:54-58
11. Keeling DM, Wilson AJG, Mackie IJ, Isenberg DA, Machin SJ. Role of β2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro. J Clin Pathol 1993;46:908-911
12. Oosting JD, Derksen RHWM, Hackeng TM, et al. In vitro studies of antiphospholipid antibodies and its cofactor, β2-glycoprotein I, show negligible effects on endothelial cell mediated protein C activation. Thromb Haemost 1991;66:666-671
13. Malia RG, Kicken S, Greaves M, Prestone FE. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol 1990;76:101-107
14. Yamazaki M, Asakura H, Jokaji H, et al. Plasma levels of lipoprotein (a) are elevated in patients with antiphospholipid antibody syndrome. Thromb Haemost 1994;71:424-427
15. Ames PJ, Tomashino C, Iannaccone L, et al. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies - a crucial role for acquired free protein S deficiency. Thromb Haemost 1996;76:190-194
16. Doig RG, O'Malley CJ, Dauer R, McGrath KM. An evaluation of 200 consecutive patients with spontaneous or recurrent thrombosis for primary hypercoagulable states. Am J Clin Pathol 1994;102:797-801
17. Roubey RAS. Mechanisms of autoantibody-mediated thrombosis. Lupus 7;1998:S114-S119
18. Del Papa N, Guidali L, Sala A, et al. Endothelial cells as target for antiphospholipid antibodies: Human polyclonal and monoclonal anti-β2-glycoprotein I antibodies react in vitro with endothelial cells through adherent β2-glycoprotein I and induce endothelial activation. Arthritis Rheum 1997;40:551-561
19. Shibata S, Harpel PC, Gharavi A, Rand J, Fillit H. Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes. Blood 1994;83:2532-2540
20. Matsuda J, Gotoh M, Saitoh N, et al. Anti-annexin antibody in the sera of patients with habitual fetal loss or preeclampsia. Thromb Res 1994;75:105-106